CIK 0001680367 · Non-accelerated filer<br>Smaller reporting company
Shattuck Labs, Inc.
Sign in to watch- Ticker
- STTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812575858
- Phone
- 512-900-4690
- Business address
- 500 W. 5TH STREET, AUSTIN, TX, 78701
- Former names
- Shattuck Labs, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 90 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | Shukla Abhinav A. Chief Technical Officer | Option exercise 10b5-1 | +12,153 | $3.57 | $43K | 98,533 |
| 2026-07-06 | Shukla Abhinav A. Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,153 | 14,140 | ||
| 2026-07-02 | Shukla Abhinav A. Chief Technical Officer | Option exercise 10b5-1 | +410 | $3.57 | $1K | 86,790 |
| 2026-07-02 | Shukla Abhinav A. Chief Technical Officer | Sale 10b5-1 | −410 | $7.01 | $3K | 86,380 |
| 2026-07-02 | Shukla Abhinav A. Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −410 | 26,293 | ||
| 2026-07-01 | Shukla Abhinav A. Chief Technical Officer | Option exercise 10b5-1 | +100 | $3.57 | $357 | 86,480 |
| 2026-07-01 | Shukla Abhinav A. Chief Technical Officer | Sale 10b5-1 | −100 | $7.07 | $707 | 86,380 |
| 2026-07-01 | Shukla Abhinav A. Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −100 | 26,703 | ||
| 2026-06-30 | Shukla Abhinav A. Chief Technical Officer | Option exercise 10b5-1 | +23,365 | $3.57 | $83K | 109,745 |
| 2026-06-30 | Shukla Abhinav A. Chief Technical Officer | Sale 10b5-1 | −23,365 | $7.08 | $165K | 86,380 |
| 2026-06-30 | Shukla Abhinav A. Chief Technical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,365 | 26,803 | ||
| 2026-06-30 | Pandite Arundathy N. Chief Medical Officer | Sale 10b5-1 | −30,000 | $7.01 | $210K | 136,219 |
| 2026-06-11 | Ashiya Mona Director | Purchase · Pre-Funded Warrants (right to buy) | +1,041,667 | 26,519,541 | ||
| 2026-06-11 | Ashiya Mona Director | Purchase · Pre-Funded Warrants (right to buy) | +208,333 | 5,303,908 | ||
| 2026-06-11 | ORBIMED ADVISORS LLC Director | Purchase · Pre-Funded Warrants (right to buy) | +1,041,667 | 26,519,541 | ||
| 2026-06-11 | ORBIMED ADVISORS LLC Director | Purchase · Pre-Funded Warrants (right to buy) | +208,333 | 5,303,908 | ||
| 2026-06-09 | SIEGALL CLAY B Director | Purchase | +62,500 | $4.00 | $250K | 318,608 |
| 2026-06-08 | ORBIMED ADVISORS LLC Director | Conversion · Pre-Funded Warrants (right to buy) | +15,366,490 | 25,477,874 | ||
| 2026-06-08 | ORBIMED ADVISORS LLC Director | Conversion · Pre-Funded Warrants (right to buy) | +3,073,298 | 5,095,575 | ||
| 2026-06-08 | ORBIMED ADVISORS LLC Director | Conversion · Common Warrants (right to buy) | −15,366,490 | 0 |
Page 1 of 9 · 170 trades